Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study.

Taeang AraiMasanori AtsukawaAkihito TsubotaHirotaka OnoTadamichi KawanoYuji YoshidaTomomi OkuboKorenobu HayamaAi Nakagawa-IwashitaNorio ItokawaChisa KondoMototsugu NagaoKatsuhiko Iwakiri

Published in: JGH open : an open access journal of gastroenterology and hepatology (2022)

Oral semaglutide treatment in patients with NAFLD complicated by T2DM improved impaired liver function, hypertriglyceridemia, insulin resistance, and hepatic steatosis, as well as improving diabetic status and reducing body weight.

Keyphrases

body weight
insulin resistance
type diabetes
glycemic control
adipose tissue
high fat diet
wound healing
cardiovascular disease
smoking cessation